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Abstract:
Objectives:
The aim of this study was to determine how tobacco control interest groups influence
tobacco policy decision-making through submissions and presentations to parliamentary
committees.
Methods:
A qualitative content analysis was used to examine the presentations and submissions
made to parliamentary committees. The sample was composed of submissions and presentations
made to parliamentary committees regarding tobacco-related legislation between 1996 and 2004.
The sample was identified from the public list of tobacco-related bills tabled in both the House of
Commons and the Senate, and using the Government of Canada website and LEGISinfo to
determine which committee reviewed the relevant bill. Committee clerks were asked to send
submissions and presentations related to specific bills identified through LEGISinfo.
Submissions and presentations were scanned and entered into QSR N6 for coding. The coding
instrument was adapted from previous studies employing qualitative content analysis. Montini
and Bero’s1 recommendations were used to evaluate the submissions and presentations.
Results:
Tobacco control interest groups did present scientific evidence to support tobacco
control. However, they underutilized the use of credible witnesses to present information at
meetings. The topics presented by tobacco control interests groups were usually relevant to the
bill being discussed.
Conclusion:

2

Tobacco Control interest groups employed some of the strategies suggested by Montini
and Bero’s1 in their attempt to influence parliament committees through submissions and
presentations. They did include scientific evidence in their submissions; however, they can
improve in the area of using credible witnesses, such as scientists and medical experts.
Incorporating Montini and Bero’s1 recommendations into lobbying efforts may increase success
in influencing committees.
Keywords: Public Health; lobbying; tobacco; consumer advocacy; federal government; Canada
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Introduction
Health advocacy, a strategy of pressuring governments for legislative and regulatory
changes that improve health, is an essential part of health promotion and public health policy.
Interest groups engage in health advocacy by providing the public and policy-makers with
information (e.g., technical or scientific), and lobbying policy-makers both in public forums and
private forums to support particular positions.2
Tobacco control is an issue that evokes strong reactions from various stakeholders
because it sits at the interface of individual versus collective rights, and health improvements
versus tax revenues. Of all stakeholders, the tobacco industry has the most political clout given
their wealth, despite their low credibility and a poor reputation.3-4 Thus, the inclusion of
tobacco control interest groups (e.g., the Non-Smokers’ Rights Association, Physicians for a
Smoke-Free Canada or the Canadian Cancer Society) in tobacco control deliberations is
necessary to advocate for public health. Otherwise, the tobacco industry and its interests might
dominate policy discussions. This is occurring in other countries, for example, in Argentina,
where tobacco control legislation is seen as weak due to strong industry pressure and an inability
to learn from the experience of other countries.5 In Asia, the tobacco industry, in its efforts to
counter and delay the process of tobacco control legislation and tobacco control regulations, is
attempting to undermine tobacco control advocacy groups, including the World Health
Organization and Asia Pacific Association of Control Tobacco.6 Effective health advocacy is
required from tobacco control interest groups in order to achieve optimal tobacco control
legislation.7
Some researchers have come to the conclusion that public forums are the most effective
means of lobbying the government for change.8 An important finding from studies of lobbying
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in different forums is that legislators have more positive attitudes toward non-for-profit health
organizations and medical professional groups than toward the tobacco industry lobbyists.9
However, legislators reported not having enough contact with non-for-profit health
organizations.9 Another study indicated that US Food and Drug Administration committees,
required to review every document submitted, took note when documents were submitted
multiple times, which may disadvantage coalitions that act on behalf of many organizations.10
Committee members also noted how the tobacco industry and tobacco control interest groups
used the same scientific articles to support their differing arguments.10 Recent and peer reviewed
articles also attracted officials’ attention.11 While these studies have focused on committee
members’ perceptions of viewed material, there is a lack of systematic understanding about the
characteristics of the submissions or presentations.
The purpose of this study was to determine how Canadian tobacco control interest groups
attempt influence tobacco policy decision-making in their written submissions and presentations
to Canadian parliamentary committees. It is important to understand how this set of advocacy
material comes across as a whole. By doing so, tobacco control interest groups can refine their
presentation strategies to legislative and regulatory committees to effectively meet the groups’
intended outcomes. According to Montini and Bero’s1 study, based on interviews with policy
makers, tobacco control interest groups should 1) present scientific evidence to support tobacco
control, 2) offer credible witnesses to present at meetings, and 3) need to understand factors,
outside of science, that affect policy-making, for example timing of legislation and lobbying
pressure. These recommendations were used to develop research questions with which to
evaluate the presentations and submissions; however the study design did not allow the authors
to examine the third recommendation. We asked if the tobacco control interest groups involved
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in health advocacy: 1) provide scientific evidence to support tobacco control? 2) offer credible
witnesses to present at meetings? and 3) present content themes that were consistent with the
theme of the bill under consideration?
Methods
Design:
This study employed a qualitative content analysis, using a coding instrument adapted
from Durrant, Wakefield, McLeod, Clegg-Smith and Chapman,12 and Wenger, Malone and
Bero13. The coding instrument was used to examine the presentations and submissions to
parliamentary committees reviewing tobacco control legislation. The coding instrument is
discussed in more detail in the Data Collection/Instrument section below. A pilot test was
conduct with two coders to refine the instrument. Operational definitions of the codes were
developed and a single coder (the primary author) was used to increase rigor. The study used
publicly available documents and not confidential or personal data; thus an ethics review was not
required.
Sample:
LEGISinfo and other Government of Canada websites were used to compile a list of bills
tabled between the 35th Parliament 2nd Session and the 37th Parliament 3rd Session (February 27,
1996 to May 23, 2004). This eight year time period was advantageous in that it included many
milestones in tobacco control legislation. Also, starting with the 35th Parliament 2nd Session,
transcripts of committee meetings are readily available online. No bills involving tobacco
control have gone to committee since the end of the 37th Parliament 3rd Session. The bill
number, title, date of first reading, committee referrals, and furthest stage or date of Royal
Assent were recorded. Ten bills regarding tobacco were identified as having gone to committee
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during this time period. These committees include The House of Commons Standing Committee
on Finance, The House of Commons Standing Committee on Health, The Senate Standing
Committee on Social Affairs, Science and Technology; The Senate Standing Committee Legal
and Constitutional Affairs; The Senate Standing Committee Energy, the Environment and
Natural Resources; and The Standing Senate Committee on Banking, Trade, and Commerce.
The clerks for the identified committees were contacted by email and requested to send any
submissions to the committee regarding the specified bills. Four of the committee clerks sent the
requested submissions in relation to nine bills; however, two bills were excluded because the
submissions only included speaking notes and no further submissions (Table 1).
The committee meeting minutes and transcripts are available on parliamentary committee
websites for bills introduced from the 35th parliament 2nd session onward. This information was
used to make a list of presenters and organizational affiliations. The presentations analyzed in
this study were extracted from these transcripts. The documents were catalogued, recording the
committee to which they were submitted, the bill they concerned, the individual or organization
making the submission, the date of submission (if available), and the title of submission. This
list was then compared to the list of presenters to identify pairs of submissions and committee
testimony.
Data Collection/Instrument:
The submissions were scanned and entered into QSR N6 for coding. The coding
instrument was an adaptation of those used in other tobacco-related studies that employ content
analysis.12-13 The coding instrument included information on the committee to which the
presentation or submission was made, the bill it concerned, which organization made the
presentation or submission, if they supported or opposed the bill, any recommendations made,
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type of document (for example presentation, brief, research, newsletter), use of scientific
evidence, and themes (for example tobacco advertising, promotion and sponsorship; youth
smoking issues; and tobacco industry; legislation and regulation). For more information
regarding the coding instrument, see Table 2.
Analysis
Emerging and predetermined themes were developed and refined during the coding
process to reflect the analytical framework. The thematic categories were not mutually
exclusive. Interpretations of findings were on-going during the coding and analysis process, and
were conducted through deliberate discussions between the authors. The themes derived from
the content analysis were compared to the themes in the bills to determine if the themes
presented were on topic.
Results and Discussion
The sample consisted of twenty-one presentations and thirty-nine submissions written in
English. The submissions and presentations related to seven bills made to four parliamentary
committees. The most common type of document submitted to committees were briefs prepared
by tobacco control interest groups (n=12). The second largest category of documents were
journal articles that the interest groups used to support their opinion (n=11). The least common
types of documents submitted were letters from tobacco control interest groups to the
committees (n=3), and questions prepared by the tobacco control interest groups directed at the
industry (n=1).
The presentations and submissions in the sample were made by eight tobacco control
interest groups. The interest groups engaged in health advocacy were categorized as Tobacco
Control Specific Organization (organizations that’s main objective is tobacco control, for
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example the Non-Smokers’ Rights Association), Health Advocacy Group (organizations that
have a broad mandate of improving health or are disease-specific, for example, the Canadian
Cancer Society), or Professional Organization (organizations that represent the interests of a
specific profession, for example, the Canadian Medical Association and the Canadian
Association of Fire Chiefs). The Non-Smokers’ Rights Association (NSRA) made the most
submissions (n=14, Table 3) however, thirteen of these were made to the same committee
regarding the same bill (C-71). The organization that made the largest total number of
presentations and submissions to committees regarding different bills was the Canadian Cancer
Society (CCS) (n=4 submissions regarding different bills, n=4 presentations).
Groups have an opportunity to express support or opposition for the bill in both their
submissions and their presentations. Professional Groups rarely expressed their view on the
legislation. The only example in the sample was the Canadian Association of Fire Chiefs who
opposed Bill 260, An Act to amend the Hazardous Products Act (fire-safe cigarettes), because
they favoured measures being taken by Health Canada. Most Health Advocacy Groups did not
express support or opposition for the bills either, but CCS did in three-quarters of submissions
and presentations in the study. The Tobacco Control Specific Organizations explicitly expressed
support or opposition more frequently (n=13) than the other two categories (combined, n=7).
They were also more likely to express this support during a presentation than in a submission.
The report written by the Standing Senate Committee on Social Affairs, Science and
Technology on Bill S-13, An Act to incorporate and to establish an industry levy to provide for
the Canadian Tobacco Industry Community Responsibility Foundation, mentions that it was
supported by over one hundred groups and organizations across Canada. The tobacco control
interest groups identified in the report included the Canadian Cancer Society, the Canadian
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Medical Association, and the Heart and Stroke Association. The only tobacco control interest
group found in this study to support Bill S-13 was the Quebec Coalition for Tobacco Control,
suggesting that organizations may state their support in other ways that were not examined in
this study, for example conversations (in person or on the telephone), through the media, or press
releases which were outside of the purview of this study.
Did the tobacco control interest groups present scientific evidence to support tobacco
control? There is evidence that scientific evidence was part of the process. This includes
providing journal articles to the committee (n= 11) and citing journal articles in briefs (n= 12 of
12). These articles include both systematic reviews and epidemiological studies. This is
important because there is strong available evidence in favour of tobacco control and this
analysis demonstrates that science was introduced to the policy making process.
Did the tobacco control interest groups offer credible witnesses to present at meetings?
The organizations did not provide scientists or medical experts as witnesses; instead the
presenters were always a spokesperson from the tobacco control interest groups. This might be
seen as a deficit in the tobacco control interest groups’ overall tobacco prevention strategy. This
is an underutilized method of influencing policymakers; both Bero et al.14 stressed the
importance of providing scientists as witnesses. This is important because policy-makers rate
witnesses provided by tobacco control interest groups as more credible than the lawyers and
scientists provided by the tobacco industry as witnesses.9 Did the tobacco control interest groups
present content themes that were consistent with the theme of the bill under consideration?
Despite not explicitly supporting the legislation in the submissions and presentations, tobacco
control interest groups were generally on topic with the bill. The most common themes tobacco
control interest groups mentioned were tobacco advertising, promotion and sponsorship (n=42,

10

combined presentations and submissions), and youth smoking (n=37, combined presentations
and submissions). This is not surprising, since two bills were regarding tobacco advertising,
promotion and sponsorship (C-71 and C-42), and three bills were regarding youth smoking (C71, S-15, and S-20). In submissions and presentations regarding C-71 and C-42, 81% mentioned
the theme of tobacco advertising, promotion and sponsorship, while 86% of the submissions and
presentations regarding C-71, S-15, and S-20 mentioned the theme of youth smoking. All of the
submissions and presentations regarding C-260 mentioned the theme of hazardous products.
Other commonly mentioned themes include education (n=23, combined presentations and
submissions), health effect of smoking (n=22, combined presentations and submissions), and tax
(n=22, combined presentations and submissions). Themes that were not commonly mentioned
include personal rights (n=2, combined presentations and submissions), environmental damage
(n=5, combined presentations and submissions), and farming/trade (n=5, combined presentations
and submissions).
Limitations
This study did not examine if submissions or presentations were more effective in
influencing policymakers; future research is needed to link the process to outcomes. As well,
this study employed a content analysis of presented material – an analysis of discursive devices
or other subtle ways to influence decision-making might reveal further insights about the policy
process.
Examining one aspect of the legislative process (i.e., Parliamentary Committee meetings)
excludes issues and topics that are dismissed at earlier stages and actors who participate in other
stages. The two committees that did not provide the requested documents were the House of
Commons Standing Committee on Finance and the Senate Standing Committee on Banking,
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Trade and Commerce, which both reviewed finance bills, including bill involving tobacco taxes.
Thus, the exclusion of these submissions limits the scope of topics and the range of actors
examined in this paper. This study provides a description of the themes presented by Tobacco
Control Interest Groups and not an evaluation of the submissions or issues presented. As well,
this study did not evaluate the scientific evidence provided by the Tobacco Control Interest
Groups to determine if it was the best available evidence or properly interpreted. This study was
unable to examine the third part of Monini and Bero’s framework1, that is, the need to
understand factors, outside of science, that affect policy-making. Due to limited resources, the
authors did not have the ability to review French language submissions; however this did not
exclude traditionally French language groups (for example, Info-Tabac and Coalition québécoise
pour le contrôle du tabac) because many of the submissions were translated into English and the
transcripts of the committee meetings are provided in both official languages.
The strength of this study is that it is the first to examine the content and organizational
affiliation of parliamentary committee submissions related to federal tobacco control bills. The
hope is that this analysis will stimulate further work in this important policy area.
Conclusion
Using presentations and submissions to parliamentary committees, the influence of
tobacco control interest groups were analyzed using a qualitative content analysis and the
framework set out by Montini and Bero’s.1 Tobacco Control Interest Groups employed some of
the strategies suggested by Montini and Bero’s1 in their attempt to influence parliament
committees through submissions and presentations. They did provide scientific evidence in both
the form of submitted articles and referencing articles in submitted documents and presentations.
There was also some evidence that they understand other factors (outside of science) that
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influence policy-making; however this needs further investigation. An area where tobacco
control interest groups can improve is in providing credible witnesses, for example, scientists
and medical experts, in addition to employees of the organization. Incorporating Montini and
Bero’s1 recommendations into lobbying efforts may increase success in influencing committees
not only for tobacco control interest groups but also for other public health advocates working in
similar areas.
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Table 1: Bills examined
Bill

Bill Title

Number
C-71

Parliament, Session

Committees

(Start/End Dates)
An Act to regulate the

35th Parl, 2nd Sess

Senate Committee –

manufacture, sale, labeling and

(February 27, 1996 –

Legal & Constitutional

promotion of tobacco products, April 27, 1997)

Affairs

to make consequential
amendments to another Act
and to repeal certain Acts
S-5

An Act to restrict the

35th Parl, 2nd Sess

Senate Committee –

manufacture, sale, importation

(February 27, 1996–

Social Affairs, Science &

and labeling of tobacco

April 27, 1997)

Technology

An Act to amend the Tobacco

36th Parl, 1st Sess

Senate Committee –

Act

(September 22, 1997–

Legal & Constitutional

September 18, 1998)

Affairs

An Act to incorporate and to

36th Parl, 1st Sess

Senate Committee –

establish an industry levy to

(September 22, 1997–

Social Affairs, Science &

provide for the Canadian

September 18, 1999)

Technology

An Act to enable and assist the

36th Parl, 2nd Sess

Senate Committee-

Canadian tobacco industry in

(October 12, 1999–

Energy, the Environment

products
C-42

S-13

Tobacco Industry Community
Responsibility Foundation
S-20
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attaining its objective of

October 22, 2000)

and Natural Resources

An Act to enable and assist the

37th Parl, 1st Sess

Senate Committee-

Canadian tobacco industry in

(January 29, 2001–

Energy, the Environment

attaining its objective of

September 16, 2002)

and Natural Resources

An Act to amend the

37th Parl, 2nd Sess

House of Commons –

Hazardous Products Act (fire-

(September 30, 2002–

Standing Committee on

safe cigarettes)

November 12, 2003)

Health

preventing the use of tobacco
by young persons in Canada
S-15

preventing the use of tobacco
by young persons in Canada
C-260

Table 2: Coding Instrument
Items in Instrument

Affiliation

Code Categories

Operational

Research Question

Definitions

Addressed

Non-Smokers’ Rights

The affiliation listed

Description of

Association

in the committee

Participants

Canadian Cancer

meeting minutes or

Society

the organization that

Ontario Campaign for

submitted documents

Action on Tobacco

to the committee

Info-Tabac
Physicians for a
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Smoke-Free Canada
National Cancer
Institute of Canada
Coalition québécoise
pour le contrôle du
tabac
Canadian Association
of Fire Chiefs
Type

Brief

A document

Description of

providing background

Participants

on the issue prepared
by the organization
Speaking notes for

Power point slides

Description of

presentation

and speaking notes

Participants

for presentations to
the committee
(corresponds a
presentation in the
committee meeting
transcript)
Letter

Letters to the
committee from the
organization
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Research/Article

Copies of journal

Description of

articles

Participants and
Question 1: provide
scientific evidence to
support tobacco
control

Questions

Lists of questions

Description of

provided by an

Participants

organization for the

Description of

committee to ask

Participants

other organizations

Description of

(e.g., tobacco industry Participants
representatives)

Description of

Transcript of

Transcripts of the

Participants

Committee Meeting

committee meetings
available on the
committee website

Newsletter/Memo

A document provide
to the committee from
an organization that
was originally
produced as an
memorandum or
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organizational
newsletter
Other

Items that did not fit
into the above
categories, e.g., other
types of documents,
art work, or
advertisements

Which Committee

House of Commons

To which committee

Description of

Standing Committee on

was the information

Participants

Health

submitted/presented

House of Commons
Standing Committee on
Finance
Senate Standing
Committee on Social
Affairs, Science and
Technology
Senate Standing
Committee on Legal
and Constitutional
Affairs
Senate Standing
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Committee on Energy,
the Environment and
Natural Resources
Senate Standing
Committee on Banking,
Trade and Commerce
Which Bill

C-11

Which bill was the

Description of

C-71

information

Participants

C-42

submitted/presented

C-26

in regard to

C-47
C-260
S-5
S-8
S-13
S-20
S-15
References

Primary research

Description of the

Question 1: provide

conducted by the

research cited by the

scientific evidence to

organization

organization in their

support tobacco

Research from other

submissions and

control

Tobacco Control

presentations

Interest Groups
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Government
Report/Publication
Journal Article
Monograph
Tobacco Industry Paper
Symposium/Conference
Presentation
Title of Presenter

Executive Director

From the committee

Question 2: Offer

Director

meeting minutes

credible witnesses to
present at meetings

President
Vice President
Program Manage
Senior Policy Analyst
Legal Counsel
Coordinator
Health Consultant
Physician/Doctor
Scientist/Researcher
Themes

Health effects of

e.g., cancer, cardio-

Question 3: what

smoking

vascular disease, lung

themes did they

disease

present in their

Second-hand smoke

The harm of second-

presentations and

issues

hand smoke, and

submissions?
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location – in public,
inside/outside, in
private.
Tobacco consumption

Rates and trends of
tobacco consumption

Tobacco advertising,

Limitations on

promotion, sponsorship

tobacco advertising,
promotion and
sponsorship

Economic issues

Costs to society,
government,
individual

Farming and trade

Economic issues
related to farming and
trade, and
compensation to
tobacco farmers

Product issue

Design of tobacco
products (e.g., vents)

Addiction

Information related to
addictive properties
of tobacco (e.g.,
nicotine)
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Youth access issues

Sales to youth, buying
for youth, product
targeted to youth (for
example, smokeless
tobacco products)

Education, prevention

Discussion of

& cessation

programmes or

programmes, services

services available or

and campaigns

proposed to educate
the public about the
harm of tobacco and
cessation programs

Environmental damage

e.g., fire, litter

Tobacco industry

References to the
tobacco industry (e.g.,
past actions, reactions
to bill)

Denormalization

Campaigns revealing
the lies to and
manipulation of the
public by the tobacco
industry

Warning labels

Warning labels on
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cigarette packages,
including the pictures
and phrases
Sales location

Issues at the location
of sale, where
cigarettes are sold,
advertising in stores.

Tax

Changes in taxation
of tobacco, use of
tobacco tax revenue

Smuggling

Smuggling from other
jurisdictions

Packaging

Plain packaging

Contraband

Contraband products

Labeling

Tobacco products
labeled Light/Mild

Other tobacco products

Smokeless tobacco,
chewing tobacco,
flavoured tobacco

Legislation/regulation

Legislation/
Regulation in other
jurisdiction and how
it can be applied to
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the situation
Legal issues

Potential legal issues
that can be foreseen
with the legislation or
faced in other
jursidications

Hazardous products

Classifying tobacco
as a hazardous
product

First Nations issues

Traditional uses of
tobacco

Personal right

Right to smoke vs.
right not to be
exposed to secondhand smoke

Other

Issues not mentioned
above

Support the Bill

Yes

Stating support or

No

opposition to the bill

Yes, with amendments

in the presentation or
presentation

Recommendations

Addition

Recommendation that
an amendment be
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added to the bill
Deletion

Recommendation that
a section be removed
from the bill

Table 3: Type of submission by tobacco interest group*
Brief

Letter

Article Questions Newsletter/

Other

Total

Memo
Non-Smokers’

2

6

3

3
14

Rights Association
Canadian Cancer

3

1

1

1
6

Society
Ontario Campaign

1

for Action on

1

Tobacco
Info-Tabac

1

Physicians for a

1

1
1

1

1

1

Smoke-Free

5

Canada
National Cancer

2

1
3

Institute of Canada
Coalition

3

2

1

1

1
8

québécoise pour le

27

contrôle du tabac
Canadian

1

Association of Fire

1

Chiefs
Total

12

3

11

1

6

6

39

* Includes multiple submissions regarding the same bill
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